1. Home
  2. AVTX vs KOPN Comparison

AVTX vs KOPN Comparison

Compare AVTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • KOPN
  • Stock Information
  • Founded
  • AVTX 2011
  • KOPN 1984
  • Country
  • AVTX United States
  • KOPN United States
  • Employees
  • AVTX N/A
  • KOPN N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • AVTX Health Care
  • KOPN Technology
  • Exchange
  • AVTX Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • AVTX 138.8M
  • KOPN 255.1M
  • IPO Year
  • AVTX 2015
  • KOPN 1992
  • Fundamental
  • Price
  • AVTX $11.33
  • KOPN $2.42
  • Analyst Decision
  • AVTX Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • AVTX 9
  • KOPN 3
  • Target Price
  • AVTX $30.14
  • KOPN $3.00
  • AVG Volume (30 Days)
  • AVTX 188.1K
  • KOPN 3.9M
  • Earning Date
  • AVTX 11-06-2025
  • KOPN 11-11-2025
  • Dividend Yield
  • AVTX N/A
  • KOPN N/A
  • EPS Growth
  • AVTX N/A
  • KOPN N/A
  • EPS
  • AVTX N/A
  • KOPN N/A
  • Revenue
  • AVTX $441,000.00
  • KOPN $46,959,478.00
  • Revenue This Year
  • AVTX N/A
  • KOPN N/A
  • Revenue Next Year
  • AVTX N/A
  • KOPN $27.17
  • P/E Ratio
  • AVTX N/A
  • KOPN N/A
  • Revenue Growth
  • AVTX N/A
  • KOPN 13.03
  • 52 Week Low
  • AVTX $3.39
  • KOPN $0.56
  • 52 Week High
  • AVTX $16.00
  • KOPN $2.67
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 62.61
  • KOPN 60.78
  • Support Level
  • AVTX $9.54
  • KOPN $2.05
  • Resistance Level
  • AVTX $12.41
  • KOPN $2.67
  • Average True Range (ATR)
  • AVTX 1.05
  • KOPN 0.21
  • MACD
  • AVTX -0.10
  • KOPN 0.02
  • Stochastic Oscillator
  • AVTX 71.28
  • KOPN 63.24

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: